• Overview
  • Eligibility
  • More info
  • Locations

Phase III Study of Cyclophosphamide, Doxorubicin and Etoposide Compared to Carboplatin and Taxol in Patients With Extensive Disease Small Cell Lung Cancer (NCT00003696)

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is most effective for extensive-stage small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens in treating patients with extensive-stage small cell lung cancer.
  • Drug: carboplatin
    • Drug: cyclophosphamide
      • Drug: doxorubicin hydrochloride
        • Drug: etoposide
          • Drug: paclitaxel
            Ages eligible for Study
            18 Years and older
            Genders eligible for Study
            All
            Accepts Healthy Volunteers
            No
            OBJECTIVES:

            - Compare the effect of cyclophosphamide, doxorubicin, and etoposide with carboplatin and paclitaxel on progression free survival in patients with extensive stage small cell lung cancer.

            - Compare the overall survival, response rate, duration of response, and toxic effects of these regimens in these patients.

            OUTLINE: This is a randomized study. Patients are stratified according to institute and performance status (0-1 vs 2-3).

            Patients are randomized to 1 of 2 treatment arms.

            - Arm I: Patients receive cyclophosphamide IV and doxorubicin IV on day 1, and etoposide IV on days 1-3 every 3 weeks.

            - Arm II: Patients receive carboplatin IV followed by paclitaxel IV over 3 hours on day 1 every 3 weeks.

            Patients with stable or responding disease are treated for up to 5 courses.

            Patients are followed every 4 weeks.

            PROJECTED ACCRUAL: A total of 250 patients (125 per treatment arm) will be accrued within 24 months for this study.

            1 locations

            Netherlands (1)
            • Vrije Universiteit Medisch Centrum
              Not specified
              Amsterdam, Netherlands, 1007 MB
            Status:
            unknown
            Type:
            Interventional
            Phase:
            Start:
            30 September, 1998
            Updated:
            15 September, 2013
            Participants:
            250
            A girl giving information about available additional trials.

            FindMeCure helps you find, understand and join clinical trials from all over the world.

            There are more clinical trials for your condition!